Lisinopril Tablet
Product Images NDC 31722-178

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Lisinopril (NDC 31722-178). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10 (10)

This text provides information about Lisinopril Tablets manufactured by Evaric Pharmaceuticals Inc. The tablets contain Lisinopril USP along with other ingredients. It specifies storage conditions and cautions that the product is for bulk shipment and needs repackaging and relabeling to comply with regulations.*

FDA Label Image

2.5 (2.5)

Description: This text provides details about Lisinopril Tablets, USP 2.5mg manufactured by Evaric Pharmaceuticals Inc. It includes information on the ingredients in each tablet, storage instructions, and a caution indicating that it is for bulk shipment and intended for further processing. The text also mentions the need for repackaging and relabeling in compliance with federal regulations.*

FDA Label Image

20 (20)

This text provides information about Lisinopril Tablets, USP 20mg manufactured by Evaric Pharmaceuticals Inc. The tablets contain Lisinopril USP, Dibasic Calcium Phosphate Dihydrate, Mannitol, Pregelatinized Starch, Ferric Oxide Red, Colloidal Silicon Dioxide, and Magnesium Stearate. The product is intended for bulk shipment and repackaging only, with specific storage instructions and cautionary notes for further processing in compliance with regulations.*

FDA Label Image

30 (30)

This text provides information about Lisinopril Tablets, USP 30mg manufactured by Evaric Pharmaceuticals Inc. in Hauppauge, NY. The tablets contain Lisinopril USP along with various other ingredients. It emphasizes that this is a bulk shipment for repackaging purposes only, and it should be stored at controlled room temperature. Additionally, it cautions that the product needs to be repackaged and relabeled according to regulations before further distribution.*

FDA Label Image

40 (40)

This is information regarding Lisinopril Tablets, USP 40mg manufactured by Evaric Pharmaceuticals Inc. in Hauppauge, NY. The tablets contain Lisinopril USP, Dibasic Calcium Phosphate Dihydrate, Mannitol, Pregelatinized Starch, Ferric Oxide Yellow, Colloidal Silicon Dioxide and Magnesium Stearate. These tablets are intended for bulk shipment and repackaging only. They need to be repacked and relabeled in compliance with the federal regulations. Storage should be done at controlled room temperature.*

FDA Label Image

5 (5)

This text provides information about Lisinopril Tablets manufactured by Evaric Pharmaceuticals Inc. in Hauppauge, NY. The tablets contain various ingredients including Lisinopril USP, Dibasic Calcium Phosphate Dihydrate, Mannitol, and others. It emphasizes that this is a bulk shipment for repackaging purposes only and must be stored at controlled room temperature. The caution advises that it needs to be repacked and relabeled in compliance with federal regulations before further processing.*

FDA Label Image

Camberlogo (Camberlogo)

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.